Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML.

Saved in:
Bibliographic Details
Title: Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML.
Authors: Hormi, Myriam1 (AUTHOR), Birsen, Rudy1 (AUTHOR), Belhadj, Maya1 (AUTHOR), Huynh, Tony1 (AUTHOR), Cantero Aguilar, Lilia1 (AUTHOR), Grignano, Eric1 (AUTHOR), Haddaoui, Lamya1,2 (AUTHOR), Guillonneau, Francois1 (AUTHOR), Mayeux, Patrick1 (AUTHOR), Hunault, Mathilde3,4 (AUTHOR), Tamburini, Jérôme1,5 (AUTHOR), Kosmider, Olivier1,6 (AUTHOR), Fontenay, Michaela1,6 (AUTHOR), Bouscary, Didier1,5 (AUTHOR), Chapuis, Nicolas1,6 (AUTHOR) nicolas.chapuis@aphp.fr
Source: European Journal of Haematology. Nov2020, Vol. 105 Issue 5, p588-596. 9p.
Database: Academic Search Ultimate
Description
ISSN:09024441
DOI:10.1111/ejh.13492